JPS5829787A - Porphyrin having hydrophobic substituent group and its complex - Google Patents

Porphyrin having hydrophobic substituent group and its complex

Info

Publication number
JPS5829787A
JPS5829787A JP56127717A JP12771781A JPS5829787A JP S5829787 A JPS5829787 A JP S5829787A JP 56127717 A JP56127717 A JP 56127717A JP 12771781 A JP12771781 A JP 12771781A JP S5829787 A JPS5829787 A JP S5829787A
Authority
JP
Japan
Prior art keywords
complex
alpha
porphyrin
expressed
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56127717A
Other languages
Japanese (ja)
Other versions
JPH0249315B2 (en
Inventor
Etsuo Hasegawa
悦雄 長谷川
Hidetoshi Tsuchida
英俊 土田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP56127717A priority Critical patent/JPH0249315B2/en
Publication of JPS5829787A publication Critical patent/JPS5829787A/en
Publication of JPH0249315B2 publication Critical patent/JPH0249315B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Gas Separation By Absorption (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

NEW MATERIAL:A porphyrin expressed by formulaI[R is >=10C alkyl, formula II (m>=1), etc.], an iron complex thereof expressed by formula III and a complex expressed by formula IV[(L) is basic axial ligand; (x) and (y) are 0 or 1, and (x+y) is 1 or 2]. EXAMPLE:meso-tetra[alpha,alpha,alpha,alpha-(o-lauroylamidophenyl)]porp hyrin. USE:An oxygen carrier capable of adsorbing and desorbing oxygen molecules. PROCESS:5,10,15,20-Tetra[alpha,alpha,alpha,alpha-(o-aminophenyl)]porph yrin is reacted with an acid chloride expressed by the formula R-COCl, e.g. H(CH2)nCOCl (10<=n<=30), in a molar amount of 4 or more times that of the porphyrin to give a porphyrin expressed by formulaI. The central iron is then introduced into the porphyrin expressed by formulaIto afford a complex expressed by formula III. The central iron of the resultant complex is then reduced with a reducing agent in the presence of an axial ligand (L) by the conventional method to give a complex expressed by formula IV.

Description

【発明の詳細な説明】 との発明は疎水性置換基を有するポルフィリンおよびそ
の錯体に関する。
DETAILED DESCRIPTION OF THE INVENTION The invention relates to porphyrins having hydrophobic substituents and complexes thereof.

ヘモグロビンやミオグロビンの鉄(In/ルフィリン錯
体は酸素分子を可逆的に吸脱着する。このような天然の
ポルフィリン鉄ω)錯体と類似の酸素吸脱着機能を持つ
錯体を合成するために、従来、多くの研究が発表されて
いる。その例としては−J、P、Collman 、A
ccounts of ChemiealR*a*ar
eh  10 265(1977)  ;  iP、B
a5oio  、  B、M。
Conventionally, many efforts have been made to synthesize complexes with oxygen adsorption and desorption functions similar to those of the iron (In/ruphyrin complexes, which reversibly adsorb and desorb oxygen molecules. Such natural porphyrin iron ω) complexes of hemoglobin and myoglobin. research has been published. Examples include - J.P., Collman, A.
ccounts of ChemicalR*a*ar
eh 10 265 (1977); iP, B
a5oio, B, M.

HoffmanおよびJ、A、Ib@ra 、 1bi
d 、、 8384(1975)などである。特に、室
温条件下で安定な酸素錯体が生成できると報告されてい
るポルフィリンfR1I)錯体として鉄ω)−5,10
,15゜20−テトラ〔α、α、α、α−(0−ピパラ
ンドフェニル)〕ポルフィリン錯体(J、P、Col1
man他Journal of Am@rican C
h@m1cal 8oei*ty 971427(19
75)参照)がある。しかし、この錯体は少菫でも水が
共存すると、直ぐに酸化されるため、酸素錯体を生成で
きなくなるのである。この丸め室温で、水が共存してい
ても酸素錯体を与える鉄(II)ポルフィリン錯体の開
発が継続して推進されている。
Hoffman and J.A., Ib@ra, 1bi.
d, 8384 (1975), etc. In particular, iron ω)-5,10 is a porphyrin fR1I) complex that is reported to be able to form a stable oxygen complex under room temperature conditions.
, 15゜20-tetra[α, α, α, α-(0-piparandophenyl)]porphyrin complex (J, P, Col1
man et al Journal of Am@rican C
h@m1cal 8oei*ty 971427 (19
75)). However, this complex is immediately oxidized when water coexists with even a small amount of violet, making it impossible to generate an oxygen complex. The development of iron(II) porphyrin complexes that provide oxygen complexes even in the coexistence of water at room temperature continues to be promoted.

本出願人は水中、室温という生理的条件下において前述
の鉄(n)−5、10、15、20−テトラ〔α、α、
α、α−(0−ピパラミドフェニル)〕ポルフィリン(
以下、F(II)Tplv pp )錯体が安定な酸素
錯体を与え、酸素キャリヤーとして働くようにするため
に、該錯体を例えばABA型ブロック共重合体の疎水性
ブロック8部に埋め込んだり、あるいはリン脂質の疎水
性二重層膜中に包接させると水またはHi□による酸化
が禁止され所要の機能を発揮させることができることを
見い出し、既に出願している(特開昭55−38812
号および特願昭56−89312号)。
The applicant has discovered that the aforementioned iron (n)-5, 10, 15, 20-tetra [α, α,
α,α-(0-piparamidophenyl)]porphyrin (
Hereinafter, in order for the F(II) Tplv pp ) complex to provide a stable oxygen complex and act as an oxygen carrier, the complex is embedded in, for example, 8 parts of a hydrophobic block of an ABA type block copolymer, or We have discovered that when lipids are included in a hydrophobic double layer membrane, oxidation by water or Hi□ is inhibited, and the desired function can be exerted.
No. 56-89312).

本発明者らは、上記の考えを発展させ、TpIマPPの
ピパロイル基を、他のより疎水性の高い置換基に代える
ことによって該ポルフィリンの疎水的性質を増大させれ
ば、より有効な酸素運搬体を提供できるであろうと考え
、本発明を完成するに至った。
The present inventors developed the above idea and found that if the hydrophobic nature of the porphyrin was increased by replacing the piparoyl group of TpI mapPP with another more hydrophobic substituent, it would be possible to make more available oxygen. The present invention was completed based on the idea that it would be possible to provide a carrier.

この発明の化合物は一般式 (ここで、Rは炭素原子数10以上のアルキル置換誘導
体、mは1以上の整数、または置換誘導体、tは0また
は1以上の整数)で示される疎水性置換基を有するポル
フィリン(メソ−テトラ〔α、α、α、α−(0−置換
アミドフェニル〕〕ポルフィリン)およびこれに中心鉄
が配位した錯体すなわち、式 で示される鉄錯体、並びに該中心鉄が2価の状態にあり
かつ塩基性軸配位子が1つまたは2つ配位した錯体すな
わち式 (ここで、Lは塩基性軸配位子、Xおよびyは0または
1であってX+yは1または2)で示される錯体である
The compound of this invention is a hydrophobic substituent represented by the general formula (where R is an alkyl substituted derivative having 10 or more carbon atoms, m is an integer of 1 or more or a substituted derivative, and t is an integer of 0 or 1 or more). porphyrin (meso-tetra[α, α, α, α-(0-substituted amidophenyl]]porphyrin) having A complex in a divalent state and coordinated with one or two basic axial ligands, that is, a complex with the formula (where L is a basic axial ligand, X and y are 0 or 1, and X+y is 1 or 2).

式(4)で示されるポルフィリンを製造するためには、
既知の方法(前記のJ、P、Co11m1n他のJou
rnal of th@Am@riean Ch*m1
eal 5oei@ty記載の方法)によって5.10
,15.20−テトラ〔α、α、α1α−(0−アミノ
フェニル)〕ポポルフィンに所定の酸塩化物(R−CO
Ct)を4倍モル以上の割合で反応させる。反応温度は
普通0℃ないし室温である。酸塩化物(R−COCt)
としては式H+cH2−y coct (ここで、nは
10以上、通常30以下)で示される脂肪族カルメン酸
塩化物、 (ここで、mは1以上、通常3以下、R1はメチ基、エ
チル基、プロピル基、塩基、臭素、)。
In order to produce the porphyrin represented by formula (4),
Known methods (Jou of J, P, Co11m1n et al.
rnal of th@Am@riean Ch*m1
eal 5.10 by the method described in oei@ty)
, 15.20-tetra[α,α,α1α-(0-aminophenyl)]poporfin with a specified acid chloride (R-CO
Ct) is reacted at a ratio of 4 times the mole or more. The reaction temperature is usually 0°C to room temperature. Acid chloride (R-COCt)
is an aliphatic carmenic acid chloride represented by the formula H+cH2-y coct (where n is 10 or more and usually 30 or less), (where m is 1 or more and usually 3 or less, R1 is a methic group or an ethyl group) , propyl group, base, bromine,).

素、メトキシ基、エトキシ基、プロ/ヤシ基、カルメン
酸メチルエステル基、カルダン酸エチルエステル基、ア
リル基等のベンゼン項置換基、aはO〜5の整数)で示
される芳香族カルメン酸塩化物、または式 は1以上通常3以下、bはO〜10の整数、R2はR1
と同様の基)で示される脂環式カルダン酸塩化物がある
Aromatic carmenic acid chloride represented by a benzene term substituent such as base, methoxy group, ethoxy group, pro/coconut group, carmenic acid methyl ester group, cardanic acid ethyl ester group, allyl group, a is an integer from O to 5) The substance or formula is 1 or more and usually 3 or less, b is an integer of O to 10, R2 is R1
There are alicyclic cardanate chlorides represented by groups similar to .

こうして得た式囚のポルフィリンに常法により中心鉄を
導入することによって式ω)で示される鉄錯体すなわち
5.10,15.20−メソ−テトラ〔α、α、α、α
−(0−1f換アミドフエニル)〕ポルフィナート鉄が
得られる。
By introducing a central iron into the thus obtained formula porphyrin by a conventional method, an iron complex represented by the formula ω), namely 5.10,15.20-meso-tetra [α, α, α, α
-(0-1f-converted amidophenyl)]porphinate iron is obtained.

式(0で示される錯体を得るためには式(B)で示され
る鉄錯体の中心鉄を適当な還元剤により軸配位子りの存
在下で常法により置元する。この塩基性軸配位子りとし
ては式 (ここで、R1は当該イミダゾールの配位を阻害しない
基好ましくは水素、メチル基、エチル基およびプロピル
基(異性体を含む)、R1〜Rdは水素または任意の置
換基例えばアルキル基、トリチル基、カルメン酸エステ
ル基)で示されるイミダゾール、または式 (ここで、RおよびR1はR1と同様の基、Rf〜・ RhはR6−R6と同様の基)で示されるピリノンがあ
る。
In order to obtain the complex represented by the formula (0), the central iron of the iron complex represented by the formula (B) is substituted with a suitable reducing agent in the presence of an axial ligand by a conventional method. The ligand is represented by the formula (where R1 is a group that does not inhibit the coordination of the imidazole, preferably hydrogen, methyl group, ethyl group, and propyl group (including isomers), and R1 to Rd are hydrogen or any substituted an imidazole represented by a group such as an alkyl group, a trityl group, a carmenic acid ester group), or an imidazole represented by the formula (where R and R1 are the same groups as R1, and Rf~.Rh is a group similar to R6-R6) There is pirinone.

式(0で示される錯体は酸素と接すると、これを軸配位
子りの一つと代って配位させ、酸素錯体を生成する。こ
れは脱気下に酸素を脱着する。
When the complex of the formula (0) comes into contact with oxygen, it coordinates in place of one of the axial ligands to form an oxygen complex, which desorbs oxygen under degassing.

この酸素吸脱着は可逆的に繰り返しおこなうことができ
、酸素吸脱着剤、酸素運搬体として作用する。
This oxygen adsorption/desorption can be repeated reversibly and acts as an oxygen adsorption/desorption agent and an oxygen carrier.

実施例1 (4)既知の方法によシ、メソ−テトラ(〇−アミノフ
ェニル)/ルフィン(4異性体の混合物)を合成し、シ
リカダう力ラム(アセトン/エーテル=1/1容量)を
用いてα、α、α、α−異性体を流出・単離した。
Example 1 (4) Meso-tetra(〇-aminophenyl)/rufin (mixture of 4 isomers) was synthesized by a known method, and silica powder (acetone/ether = 1/1 volume) was synthesized. The α, α, α, α-isomers were extracted and isolated using the following method.

(B)  メソ−テトラ〔α、α、α、α−(0−アミ
ノフェニル〕ポルフィン約o、 3 tr ’k 含t
rアセトンエーテル(1/1)溶液的300−を水冷攪
拌した。
(B) Meso-tetra[α, α, α, α-(0-aminophenyl]porphine approximately o, 3 tr 'k included t
A solution of 300 ml of acetone ether (1/1) was stirred under water cooling.

これに乾燥ピリシン2−1次いで塩化ラウロイル2.5
−を加え、水冷下で1時間攪拌後、室温下で2時間攪拌
した。蒸発させて得たtA清をCHC/−、200−に
溶解し、希アンモニア水で洗浄後、水洗し、ゼライトで
処理し、水洗した。
Add to this 2-1 dry pyricin, then 2.5 lauroyl chloride.
- was added, and the mixture was stirred for 1 hour under water cooling, and then stirred for 2 hours at room temperature. The tA liquid obtained by evaporation was dissolved in CHC/-, 200-, washed with dilute ammonia water, washed with water, treated with gelite, and washed with water.

これをNa2SO4で脱水処理した後、ろ過し、ろ液を
浴@30℃以下で蒸発乾固した。これをシリカダルカラ
ムにて分画精製し、ベンゼン/エーテル(7/’3) 
(容t/容量)流出の目的部を果め、これを蒸発乾固し
た。再度、シリカカラムラムによる精製をおこなった。
This was dehydrated with Na2SO4, filtered, and the filtrate was evaporated to dryness in a bath below 30°C. This was fractionated and purified using a silica dull column, and benzene/ether (7/'3)
(Volume t/volume) The purpose of the effluent was completed and it was evaporated to dryness. Purification using a silica column was performed again.

収量的0.56 fr(収率的901)。これを、更に
、シ9力rルカ2人で精製した( BioBsads 
8X−8,ベンゼン)。
Yield 0.56 fr (yield 901). This was further refined by two people (BioBsads
8X-8, benzene).

電場脱着マススペクトル測定:M+1(1403)(C
92H12□N804の分子量1402)。元素分析値
(重414):C78,66(78,7)i、H8,5
2(8,7)、N7.60(8,0)但し、括弧内の値
はC92H12□N804に対する計算値を示す。
Electric field desorption mass spectrum measurement: M+1 (1403) (C
Molecular weight of 92H12□N804: 1402). Elemental analysis value (heavy 414): C78,66 (78,7)i, H8,5
2 (8,7), N7.60 (8,0) However, the values in parentheses indicate calculated values for C92H12□N804.

13C−核磁気共鳴スペクトル(溶媒CDCl3゜TM
S基準)δ(pprn) : 170.5 (1) −
147,0(2)、138.0(3)、134.8(4
)。
13C-Nuclear magnetic resonance spectrum (solvent CDCl3°TM
S standard) δ (pprn): 170.5 (1) -
147.0 (2), 138.0 (3), 134.8 (4
).

131.6(5) 、129.8(6) 、 122.
8(7)。
131.6(5), 129.8(6), 122.
8(7).

121.1(8)、11−5.0(9)、37.0(1
0)。
121.1 (8), 11-5.0 (9), 37.0 (1
0).

31.8(11)、29.4.29.2及び28.9(
12,13,14)、25.0(15)。
31.8(11), 29.4.29.2 and 28.9(
12, 13, 14), 25.0 (15).

22.6(16)、14.0(17)但し、括弧内の数
値は下肥の炭素を示す。
22.6 (16), 14.0 (17) However, the numbers in parentheses indicate the carbon in the manure.

実m何2 実施例1で合成したメソ−テトラ〔α、α、α、α−(
0−ラウロイルア(ドフェニル〕〕ポルフィ70、33
 frを乾燥テトラヒドロフラン25dK溶解し、N2
置換を行った。これに、2.6−ルチゾン0.1 d 
x次いで臭化第一鉄(FeBr2) 0.3 frを加
え、加熱下に直流させた。2時間後、さらにFeBr2
を0.1 tr添加し、2時間加熱後、蒸発乾固し、残
固体を、クロロホルムを流出溶媒として、塩基性アルミ
ナカラムで精製をおこない、流出液に0.2−の濃HB
rを加え振盪後、水洗した。クロロホルム層をNa25
o4で脱水処理した後、蒸発乾固し、一旦減圧乾燥した
。これをrルカラム精製した(B量oB@ada 5X
−8,ベンゼン)。薄層クロマトグラフィー(メルクシ
リカグルグレート、ベンゼン/エーテル=1/1) :
Rf=0.89(モノスポット)。電場脱着マススペク
トル測定: M + 1 = 1457 (C,2H,
2oN804F@、の分子量1456)。元素分析値(
重量4):C71,50(71,9)、N7.61(7
,8)、N 7.03 (7,3)但し、括弧内の値は
、C92H12(IN60.F@Brに対する計算値を
示す。赤外吸収スペクトル(KBr y’イスク、 e
ffl  ) *2930  、2860 (Van 
 、 Vm (CH2))、1680(アミドI吸収帯
)、i s s o (ve−バフェニル核)、760
(δCH2(面外)(〇−置置換フェニル核。
Meso-tetra [α, α, α, α-(
0-Lauroilua (dophenyl)] Porphy 70, 33
Dissolve fr in 25 dK of dry tetrahydrofuran and N2
Replacement was made. To this, 0.1 d of 2,6-lutisone
Next, 0.3 fr of ferrous bromide (FeBr2) was added, and a direct current was applied while heating. After 2 hours, more FeBr2
After heating for 2 hours, evaporate to dryness, and purify the remaining solid with a basic alumina column using chloroform as the effluent solvent.
After adding r and shaking, the mixture was washed with water. chloroform layer with Na25
After dehydration treatment with O4, it was evaporated to dryness and once dried under reduced pressure. This was purified by column (B amount oB@ada 5X
-8, benzene). Thin layer chromatography (Merck silica glucose, benzene/ether = 1/1):
Rf=0.89 (mono spot). Electric field desorption mass spectrum measurement: M + 1 = 1457 (C, 2H,
2oN804F@, molecular weight 1456). Elemental analysis value (
Weight 4): C71,50 (71,9), N7.61 (7
, 8), N 7.03 (7, 3) However, the values in parentheses indicate the calculated values for C92H12 (IN60.F@Br.
ffl) *2930, 2860 (Van
, Vm (CH2)), 1680 (amide I absorption band), isso (ve-baphenyl nucleus), 760
(δCH2 (out-of-plane) (〇-substituted phenyl nucleus.

実施例3 実施例2で合成した鉄−メソーテト2〔α、α。Example 3 Iron-mesotet 2 [α, α.

α、α−(0−2ウロイルアミドフエニル)〕4ルフィ
ン・Br5X10  モルおよび1.2−ノメチルイミ
タソール1.5 X 10  モルヲトルエン7−に溶
”ML、N2ガスで置換した後、過剰のNa2S2O4
を含む水5dを加えて充分振盪し、静置した。ベンゼン
層を分離し、脱酸素処理したモレキーラ=シーゴス41
で脱水し、所望のF・(If)ポルフィリン錯体(式(
0に相当)の乾燥ベンゼン(但し、10”” Mの水を
混入)溶液を調製した。この可視吸収スペクトルを第1
図の曲線輿で示す・これはλmix 560 nm e
 535 nrn(肩)を持つ5配位型デオキシ錯体す
なわち、F@1)−メソ−テトラ〔α、α、α、α−(
0−ラウロイルアミドフェニル)L/ルフィン−七ノ(
1,2−ツメチルイミダゾール)1体である。これに酸
素ガスを接触させたところ、スペクトル変化が直ちに観
測され、λmhx 549 nm (酸素錯体)を得た
(曲線b)。可視吸収ス(クトルの経時変化から、25
℃においてこの酸素錯体の安定性は20分以上であった
。また、−10Cにおけるこの酸素錯体の安定性は1時
間以上であった。
α, α-(0-2 uroylamidophenyl)]4rufin・Br5×10 moles and 1.5×10 moles of 1,2-nomethylimitasole were dissolved in toluene 7-ML, and after replacing with N2 gas, Excess Na2S2O4
5 d of water was added thereto, thoroughly shaken, and allowed to stand still. Molequilla-Xigos 41 with benzene layer separated and deoxidized
The desired F.(If)porphyrin complex (formula (
A solution of dry benzene (corresponding to 0%) with 10""M water was prepared. This visible absorption spectrum is
Shown by the curved line in the figure・This is λmix 560 nm e
535 A five-coordinated deoxy complex with nrn (shoulder), i.e. F@1)-meso-tetra[α, α, α, α-(
0-lauroylamidophenyl) L/rufin-nanino(
1,2-methylimidazole). When this was brought into contact with oxygen gas, a spectral change was immediately observed, and λmhx 549 nm (oxygen complex) was obtained (curve b). Visible absorption (from the change in color over time, 25
The stability of this oxygen complex at 0.degree. C. was greater than 20 minutes. Moreover, the stability of this oxygen complex at -10C was more than 1 hour.

実施例4 実施例3において、トルエンの代すニベンゼンを用い更
に、4す(スチレン) 0.1 frを添加した以外は
、同様にしてrl■)デオキシ繊体溶液を調製した。こ
れを凍結乾燥処理してベンゼンを除去し錯体の分数した
ポリスチレン粒子を得た。これに、窒素ガス飽和水10
5g1gを添加し、固体粒子分散水を調製した。これは
第2図の曲線Cに示す様に、N2下においては、5配位
型rオキシ体(F・(■)−メソ−テトラ〔α、α、α
、α−(0−ラウロイルアミドフェニル)]]/ルフィ
ンーモノー1.2−ジメチルイミダゾール)m体)に相
当するスペクトル(λmax 560 nm、532 
nm (屑))を得た。この固体分散水に0□ガスを導
入した所、直ちに酸素化錯体のスペクトル(λwax 
550 am )に変化した(曲線d)。これに、CO
ガスを導入し死所、直ちにF・(II) CO錯体に相
当するスペクトル(λrnax530 am )を与え
た(曲線e)、25℃、水中における酸素錯体の安定性
は、10時以上であった。
Example 4 A deoxy fiber solution was prepared in the same manner as in Example 3 except that nibenzene was used instead of toluene and 0.1 fr of styrene was added. This was freeze-dried to remove benzene and obtain polystyrene particles containing a fraction of the complex. To this, add 10 ml of nitrogen gas saturated water.
5g/g was added to prepare solid particle dispersion water. As shown in curve C in Figure 2, under N2, the 5-coordinate r-oxy form (F・(■)-meso-tetra[α, α, α
, α-(0-lauroylamidophenyl)]/rufin-mono 1,2-dimethylimidazole) m form) (λmax 560 nm, 532
nm (dust)) was obtained. When 0□ gas was introduced into this solid dispersion water, the spectrum of the oxygenated complex (λwax
550 am) (curve d). In addition, CO
As soon as the gas was introduced, a spectrum (λrnax 530 am) corresponding to the F·(II) CO complex was obtained (curve e). The stability of the oxygen complex in water at 25° C. was more than 10 hours.

実施例5 実施例1(B)において、塩化ラウロイルの代りに塩化
シクロヘキサンカルメン酸を用いた以外は、同様の手法
に従い、5.10,15.20−テトラ(α、α、α、
α−(0−シクロヘキサノイルアンドフェニル))ポル
フィリ漕合成した0元素分析値(重t%) : C77
,13(77,6)、f(6,71(6,6)、N 1
0.22 (10,1)但し、括弧内の値は、C72H
74N804に対する計算値を示す。電場脱着マスス(
クトル:M+1−1115(分子蓋1114)。
Example 5 5.10,15.20-tetra(α, α, α,
α-(0-Cyclohexanoylandphenyl)) porphyry tank synthesized 0 element analysis value (weight t%): C77
,13(77,6),f(6,71(6,6),N 1
0.22 (10,1) However, the value in parentheses is C72H
Calculated values for 74N804 are shown. Electric field desorption mass (
Cuttle: M+1-1115 (Molecular Lid 1114).

実施的6 実施例5において合成した5、10,15゜20−テト
ラ(α、α、α、α−(0−シクロヘキサノイルアンド
フェニル))/ルフィンに、実施例2に従い中心鉄を導
入した。元素分析値(重in):C68,87(69,
2)、H5,71(5,8)、N8.82(8,9)、
但し、括弧内の値は、C72)[74NaOa F@ 
B rに対する計算値を示す。
Practical 6 A central iron was introduced into the 5,10,15°20-tetra(α,α,α,α-(0-cyclohexanoylandophenyl))/rufin synthesized in Example 5 according to Example 2. . Elemental analysis value (heavy in): C68,87 (69,
2), H5,71 (5,8), N8.82 (8,9),
However, the values in parentheses are C72) [74NaOa F@
Calculated values for B r are shown.

実施例7 実施例1(B)において、塩化ラウロイルの代りに、塩
化フェニル酢酸を用いた以外は同様の手法に従い5.1
0,15.20−テトラ(α、α。
Example 7 5.1 was carried out in the same manner as in Example 1 (B) except that phenylacetic acid chloride was used instead of lauroyl chloride.
0,15.20-tetra(α,α.

α、α−(0−フェニルアセチルアミドフェニル))ポ
ルフィリンを合成した後、実施例2に従い中心鉄を導入
した。電場脱着マスス(クトル二M + 1−1200
 (C,6H66N、04F・の分子蓋1200)。元
素分析値(重量憾):C70゜92(71−3)、H4
,65(4,4)、N8.41C8,8)。但し、括弧
内の数値は、 C76H54NB04F@Brに対する計算値を示す。
After synthesizing α,α-(0-phenylacetylamidophenyl))porphyrin, central iron was introduced according to Example 2. Electric field desorption mass (Kutoruni M + 1-1200
(Molecular lid 1200 of C, 6H66N, 04F). Elemental analysis value (weight): C70°92 (71-3), H4
, 65(4,4), N8.41C8,8). However, the numbers in parentheses indicate calculated values for C76H54NB04F@Br.

実開1 を用い九以外は、同様の反応を行い、精製した。Actual opening 1 The same reaction was carried out and purified using 9 except for 9.

元素分析値(を量係):C81,53(81,2)、H
10,61(10,7)、H5,02(5,1)、括弧
内の値はC148H234N804の計算値を示す。こ
れに、実施例2に従い、中心鉄を導入した。元素分析値
(重量4 ) : C76,18(76,6)、1(1
0,,37(10,1)、N4.81(4,8)、但し
括弧内の値は、CH4BH252NB04F@ Brの
計算値を示す。
Elemental analysis value (quantity): C81,53 (81,2), H
10,61 (10,7), H5,02 (5,1), values in parentheses indicate calculated values of C148H234N804. A central iron was introduced into this according to Example 2. Elemental analysis value (weight 4): C76,18 (76,6), 1 (1
0,,37 (10,1), N4.81 (4,8), however, the values in parentheses indicate the calculated values of CH4BH252NB04F@Br.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図および第2図はこの発明のポルフィリン鉄錯体の
酸素化前後における可視吸収ス(クトルを示すグラフ。 出願人代理人  弁理士 鈴 江 武 彦1下η   
Figures 1 and 2 are graphs showing the visible absorption spectrum before and after oxygenation of the porphyrin iron complex of the present invention. Applicant's agent: Takehiko Suzue, patent attorney
~

Claims (5)

【特許請求の範囲】[Claims] (1)一般式 (ここで、RB炭嵩原子数lO以上のアルキル基、−+
 CH2−+i基もしくはそのベンゼン積置換誘導体、
mは1以上の整数、または −(CH2h(◇もしくはそのシクロヘキサン櫃置換誘
導体、tは0または1以上の整数)で示される疎水性置
換基を有するポルフィクンおよびこれに鉄イオンが配位
した錯体並びに該鉄イオンが2価の状態にあってかつそ
れに塩基性軸配位子が配位した錯体。
(1) General formula (here, an alkyl group having RB carbon atoms number lO or more, -+
CH2−+i group or its benzene product substituted derivative,
m is an integer of 1 or more, or a porphyne having a hydrophobic substituent represented by -(CH2h (◇ or its cyclohexane-substituted derivative, t is an integer of 0 or 1 or more) and a complex in which an iron ion is coordinated thereto; A complex in which the iron ion is in a divalent state and is coordinated with a basic axial ligand.
(2)  アルキル基が30個までの炭素原子を有する
特許請求の範囲第1項記載の4ルフイリンおよびその錯
体。
(2) 4-luphyrin and its complexes according to claim 1, in which the alkyl group has up to 30 carbon atoms.
(3)mが3までである特許請求の範囲第1項記載の4
ルフイリンおよびその錯体。
(3) 4 as described in claim 1, where m is up to 3
Lufilin and its complexes.
(4)tが3までである特許請求の範囲第1項記載の4
ルフイリンおよびその錯体。
(4) 4 as described in claim 1, where t is up to 3
Lufilin and its complexes.
(5)  塩基性軸配位子がイ5ダ!−ル誘導体ま九は
ぎリジン誘導体である%1FFill!求の範囲第1項
記載の錯体。
(5) The basic axial ligand is I5! %1FFill, which is a lysine derivative! The complex according to item 1 of the desired range.
JP56127717A 1981-08-17 1981-08-17 SOSUISEICHIKANKIOJUSURUHORUFUIRINOYOBISONOSAKUTAI Expired - Lifetime JPH0249315B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56127717A JPH0249315B2 (en) 1981-08-17 1981-08-17 SOSUISEICHIKANKIOJUSURUHORUFUIRINOYOBISONOSAKUTAI

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56127717A JPH0249315B2 (en) 1981-08-17 1981-08-17 SOSUISEICHIKANKIOJUSURUHORUFUIRINOYOBISONOSAKUTAI

Publications (2)

Publication Number Publication Date
JPS5829787A true JPS5829787A (en) 1983-02-22
JPH0249315B2 JPH0249315B2 (en) 1990-10-29

Family

ID=14966958

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56127717A Expired - Lifetime JPH0249315B2 (en) 1981-08-17 1981-08-17 SOSUISEICHIKANKIOJUSURUHORUFUIRINOYOBISONOSAKUTAI

Country Status (1)

Country Link
JP (1) JPH0249315B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61130220A (en) * 1984-11-26 1986-06-18 エフアモル・リミテツド Manufacture of antitumoral drug
WO2003011866A1 (en) * 2001-07-30 2003-02-13 Japan Science And Technology Corporation Porphyrin-metal complexes and oxygen infusions containing the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61130220A (en) * 1984-11-26 1986-06-18 エフアモル・リミテツド Manufacture of antitumoral drug
WO2003011866A1 (en) * 2001-07-30 2003-02-13 Japan Science And Technology Corporation Porphyrin-metal complexes and oxygen infusions containing the same
US7125862B2 (en) 2001-07-30 2006-10-24 Japan Science And Technology Agency Porphyrin-metal complexes and oxygen infusions containing the same

Also Published As

Publication number Publication date
JPH0249315B2 (en) 1990-10-29

Similar Documents

Publication Publication Date Title
Momenteau et al. Synthesis and characterization of a new series of iron (II) single-face hindered porphyrins. Influence of central steric hindrance upon carbon monoxide and oxygen binding
US6008198A (en) Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same
KR960004619B1 (en) Oxygen-permeable polymeric membranes
EP0066884B1 (en) Oxygen-adsorbing and desorbing agent
US20090182125A1 (en) Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier
JPS5829787A (en) Porphyrin having hydrophobic substituent group and its complex
JP3312953B2 (en) Tetraphenylporphyrin metal complex having 2-position side chain and method for producing the same
JP3816767B2 (en) Porphyrin metal complex and oxygen infusion containing it
JP3455174B2 (en) Substituted tetraphenylporphyrin compounds having a basic axial ligand
JP2008031103A (en) Porphyrin compound having histidine derivative bonded thereto and artificial oxygen carrier comprising the same
Inaba et al. Synthesis of a complementary dimer from mono (imidazolyl)-substituted cobalt (II) porphyrin as a new artificial T-form hemoglobin
JP3405741B2 (en) Porphyrin metal complexes with proximal bases
US5194603A (en) 5,10,15,20-tetra(2&#39;,6&#39;-dipivaloyloxyphenyl)porphinato metal complex
WO2006001429A1 (en) Porphyrin compound having succinimidyl group or metal complex thereof, and albumin having porphyrin metal complex bonded thereto and oxygen infusion containing the same
WO2006001430A1 (en) PORPHYRIN COMPOUND HAVING α3β SUBSTITUTION STRUCTURE, METAL COMPLEX THEREOF AND OXYGEN INFUSION CONTAINING SAME
JPS59179128A (en) Oxygen adsorbing and desorbing agent
JP3390035B2 (en) Porphyrin metal complexes with dialkylglycerophosphocholine groups
Shade et al. Chiral iron complexes (η5-C5H4CH (Ph) Me) Fe (CO)(L) X (L= phosphine, phosphite; X= acyl, alkyl, halide, hydride)
JPS5810132B2 (en) Oxygen adsorption/desorption agent
JP3604556B2 (en) Amphiphilic tetraphenylporphyrin metal complex having a side chain at two positions and method for producing the same
JPH0152054B2 (en)
JPS635010B2 (en)
JPH0458481B2 (en)
JPS58213779A (en) Iron-tetraphenylporphyrin complex having hydrophobic alkyl group and agent for adsorption and desorption of oxygen
JP2002128782A (en) Porphyrin aggregate